Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Oncolytic Virus). Showing records 1 – 30 of 99 total matches.

[1] [2] [3] [4]

Search Limiters

Last 2 Years | English Only

Levels

Country

▼ Search Limiters


University of Ottawa

1. Evgin, Laura. Enhancing the Delivery of Oncolytic Vaccinia Virus to the Tumors of Hosts with Pre-Existing Immunity .

Degree: 2015, University of Ottawa

Oncolytic viruses (OVs) have begun to show their promise in the clinical setting, however these results have been predominantly associated with loco-regional administration of virus.… (more)

Subjects/Keywords: Oncolytic virus; Complement

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Evgin, L. (2015). Enhancing the Delivery of Oncolytic Vaccinia Virus to the Tumors of Hosts with Pre-Existing Immunity . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/32423

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Evgin, Laura. “Enhancing the Delivery of Oncolytic Vaccinia Virus to the Tumors of Hosts with Pre-Existing Immunity .” 2015. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/32423.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Evgin, Laura. “Enhancing the Delivery of Oncolytic Vaccinia Virus to the Tumors of Hosts with Pre-Existing Immunity .” 2015. Web. 21 Jan 2021.

Vancouver:

Evgin L. Enhancing the Delivery of Oncolytic Vaccinia Virus to the Tumors of Hosts with Pre-Existing Immunity . [Internet] [Thesis]. University of Ottawa; 2015. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/32423.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Evgin L. Enhancing the Delivery of Oncolytic Vaccinia Virus to the Tumors of Hosts with Pre-Existing Immunity . [Thesis]. University of Ottawa; 2015. Available from: http://hdl.handle.net/10393/32423

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Ottawa

2. Pelin, Adrian. Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential .

Degree: 2019, University of Ottawa

 Vaccinia virus has a large and still incompletely understood genome although several strains of this virus are already in clinical development. For the most part,… (more)

Subjects/Keywords: Vaccinia; Oncolytic Virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pelin, A. (2019). Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/39909

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Pelin, Adrian. “Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential .” 2019. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/39909.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Pelin, Adrian. “Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential .” 2019. Web. 21 Jan 2021.

Vancouver:

Pelin A. Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential . [Internet] [Thesis]. University of Ottawa; 2019. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/39909.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Pelin A. Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential . [Thesis]. University of Ottawa; 2019. Available from: http://hdl.handle.net/10393/39909

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


McMaster University

3. Cuddington, Breanne. Characterization of Oncolytic Bovine Herpesvirus Type 1.

Degree: PhD, 2014, McMaster University

Oncolytic viruses (OV) are a promising alternative cancer therapy due to their specificity and lack of debilitating side effects, such as those which typically accompany… (more)

Subjects/Keywords: oncolytic virus; breast cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cuddington, B. (2014). Characterization of Oncolytic Bovine Herpesvirus Type 1. (Doctoral Dissertation). McMaster University. Retrieved from http://hdl.handle.net/11375/16561

Chicago Manual of Style (16th Edition):

Cuddington, Breanne. “Characterization of Oncolytic Bovine Herpesvirus Type 1.” 2014. Doctoral Dissertation, McMaster University. Accessed January 21, 2021. http://hdl.handle.net/11375/16561.

MLA Handbook (7th Edition):

Cuddington, Breanne. “Characterization of Oncolytic Bovine Herpesvirus Type 1.” 2014. Web. 21 Jan 2021.

Vancouver:

Cuddington B. Characterization of Oncolytic Bovine Herpesvirus Type 1. [Internet] [Doctoral dissertation]. McMaster University; 2014. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/11375/16561.

Council of Science Editors:

Cuddington B. Characterization of Oncolytic Bovine Herpesvirus Type 1. [Doctoral Dissertation]. McMaster University; 2014. Available from: http://hdl.handle.net/11375/16561


University of Ottawa

4. Roy, Dominic. Improving the Delivery and Replication of Oncolytic Viruses .

Degree: 2016, University of Ottawa

 The optimal route for clinical delivery of oncolytic viruses (OVs) is thought to be intravenous (IV) injection; however, the immune system is armed with several… (more)

Subjects/Keywords: cancer; oncolytic virus; delivery; RNAi

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Roy, D. (2016). Improving the Delivery and Replication of Oncolytic Viruses . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/35227

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Roy, Dominic. “Improving the Delivery and Replication of Oncolytic Viruses .” 2016. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/35227.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Roy, Dominic. “Improving the Delivery and Replication of Oncolytic Viruses .” 2016. Web. 21 Jan 2021.

Vancouver:

Roy D. Improving the Delivery and Replication of Oncolytic Viruses . [Internet] [Thesis]. University of Ottawa; 2016. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/35227.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Roy D. Improving the Delivery and Replication of Oncolytic Viruses . [Thesis]. University of Ottawa; 2016. Available from: http://hdl.handle.net/10393/35227

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Ottawa

5. Watson, Margaret. Characterizing a Novel Viral Sensitizer BI-D1870 .

Degree: 2019, University of Ottawa

Oncolytic viruses (OVs) are an emerging cancer therapy that use an oncotropic virus to selectively infect and kill cancer cells, as well as stimulate long-lasting… (more)

Subjects/Keywords: Oncolytic virus; Cancer therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Watson, M. (2019). Characterizing a Novel Viral Sensitizer BI-D1870 . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/39364

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Watson, Margaret. “Characterizing a Novel Viral Sensitizer BI-D1870 .” 2019. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/39364.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Watson, Margaret. “Characterizing a Novel Viral Sensitizer BI-D1870 .” 2019. Web. 21 Jan 2021.

Vancouver:

Watson M. Characterizing a Novel Viral Sensitizer BI-D1870 . [Internet] [Thesis]. University of Ottawa; 2019. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/39364.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Watson M. Characterizing a Novel Viral Sensitizer BI-D1870 . [Thesis]. University of Ottawa; 2019. Available from: http://hdl.handle.net/10393/39364

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Ottawa

6. Scut, Elena. Characterization of the Immune Response Induced by Rhabdovirus-Infected Leukemia Cell Vaccines.

Degree: MSc, Médecine / Medicine, 2020, University of Ottawa

 Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are blood cancers that are often treated with stem cell transplantation (SCT). Since SCT treatments have… (more)

Subjects/Keywords: Cell vaccine; Oncolytic virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Scut, E. (2020). Characterization of the Immune Response Induced by Rhabdovirus-Infected Leukemia Cell Vaccines. (Masters Thesis). University of Ottawa. Retrieved from http://dx.doi.org/10.20381/ruor-25170

Chicago Manual of Style (16th Edition):

Scut, Elena. “Characterization of the Immune Response Induced by Rhabdovirus-Infected Leukemia Cell Vaccines.” 2020. Masters Thesis, University of Ottawa. Accessed January 21, 2021. http://dx.doi.org/10.20381/ruor-25170.

MLA Handbook (7th Edition):

Scut, Elena. “Characterization of the Immune Response Induced by Rhabdovirus-Infected Leukemia Cell Vaccines.” 2020. Web. 21 Jan 2021.

Vancouver:

Scut E. Characterization of the Immune Response Induced by Rhabdovirus-Infected Leukemia Cell Vaccines. [Internet] [Masters thesis]. University of Ottawa; 2020. [cited 2021 Jan 21]. Available from: http://dx.doi.org/10.20381/ruor-25170.

Council of Science Editors:

Scut E. Characterization of the Immune Response Induced by Rhabdovirus-Infected Leukemia Cell Vaccines. [Masters Thesis]. University of Ottawa; 2020. Available from: http://dx.doi.org/10.20381/ruor-25170


University of Miami

7. Heiber, Joshua F. Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector.

Degree: PhD, Microbiology and Immunology (Medicine), 2011, University of Miami

Oncolytic virotherapy is emerging as a new treatment option for cancer patients. At present, there are relatively few oncolytic virus clinical trials that are underway… (more)

Subjects/Keywords: Vesicular Stomatits Virus; p53, oncolytic virus, oncolytic virotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Heiber, J. F. (2011). Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector. (Doctoral Dissertation). University of Miami. Retrieved from https://scholarlyrepository.miami.edu/oa_dissertations/600

Chicago Manual of Style (16th Edition):

Heiber, Joshua F. “Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector.” 2011. Doctoral Dissertation, University of Miami. Accessed January 21, 2021. https://scholarlyrepository.miami.edu/oa_dissertations/600.

MLA Handbook (7th Edition):

Heiber, Joshua F. “Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector.” 2011. Web. 21 Jan 2021.

Vancouver:

Heiber JF. Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector. [Internet] [Doctoral dissertation]. University of Miami; 2011. [cited 2021 Jan 21]. Available from: https://scholarlyrepository.miami.edu/oa_dissertations/600.

Council of Science Editors:

Heiber JF. Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector. [Doctoral Dissertation]. University of Miami; 2011. Available from: https://scholarlyrepository.miami.edu/oa_dissertations/600


University of Newcastle

8. Haley, Erin. Enteroviral mediated oncolysis of cancer: evaluation of efficacy and obstacles to therapeutic success.

Degree: PhD, 2009, University of Newcastle

Research Doctorate - Doctor of Philosophy (PhD)

A number of oncolytic picornaviruses are currently under evaluation as potential therapeutic agents for a range of human… (more)

Subjects/Keywords: oncolytic virus; enterovirus; cancer; gastric; colorectal

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Haley, E. (2009). Enteroviral mediated oncolysis of cancer: evaluation of efficacy and obstacles to therapeutic success. (Doctoral Dissertation). University of Newcastle. Retrieved from http://hdl.handle.net/1959.13/38508

Chicago Manual of Style (16th Edition):

Haley, Erin. “Enteroviral mediated oncolysis of cancer: evaluation of efficacy and obstacles to therapeutic success.” 2009. Doctoral Dissertation, University of Newcastle. Accessed January 21, 2021. http://hdl.handle.net/1959.13/38508.

MLA Handbook (7th Edition):

Haley, Erin. “Enteroviral mediated oncolysis of cancer: evaluation of efficacy and obstacles to therapeutic success.” 2009. Web. 21 Jan 2021.

Vancouver:

Haley E. Enteroviral mediated oncolysis of cancer: evaluation of efficacy and obstacles to therapeutic success. [Internet] [Doctoral dissertation]. University of Newcastle; 2009. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/1959.13/38508.

Council of Science Editors:

Haley E. Enteroviral mediated oncolysis of cancer: evaluation of efficacy and obstacles to therapeutic success. [Doctoral Dissertation]. University of Newcastle; 2009. Available from: http://hdl.handle.net/1959.13/38508


University of Ottawa

9. Alkayyal, Almohanad. Exploiting the Antitumor Immune Response Using IL-12 Armed Oncolytic MG1 Virus In An Infected Cell Vaccine .

Degree: 2016, University of Ottawa

 Despite improvements in chemotherapy and radical surgical debulking, peritoneal carcinomatosis (PC) remains among the most common causes of death for abdominal cancers. Immunotherapies have demonstrated… (more)

Subjects/Keywords: Oncolytic virus; Cancer vaccines; Interleukin-12

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alkayyal, A. (2016). Exploiting the Antitumor Immune Response Using IL-12 Armed Oncolytic MG1 Virus In An Infected Cell Vaccine . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/35599

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Alkayyal, Almohanad. “Exploiting the Antitumor Immune Response Using IL-12 Armed Oncolytic MG1 Virus In An Infected Cell Vaccine .” 2016. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/35599.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Alkayyal, Almohanad. “Exploiting the Antitumor Immune Response Using IL-12 Armed Oncolytic MG1 Virus In An Infected Cell Vaccine .” 2016. Web. 21 Jan 2021.

Vancouver:

Alkayyal A. Exploiting the Antitumor Immune Response Using IL-12 Armed Oncolytic MG1 Virus In An Infected Cell Vaccine . [Internet] [Thesis]. University of Ottawa; 2016. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/35599.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Alkayyal A. Exploiting the Antitumor Immune Response Using IL-12 Armed Oncolytic MG1 Virus In An Infected Cell Vaccine . [Thesis]. University of Ottawa; 2016. Available from: http://hdl.handle.net/10393/35599

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Oxford

10. Calderon, Hugo. Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response.

Degree: PhD, 2017, University of Oxford

Oncolytic viruses are characterised by their ability to selectively infect and kill tumour cells. Recently it has emerged that they can exert an additional anticancer… (more)

Subjects/Keywords: 616.99; Oncology; Cancer; Immunotherapy; Oncolytic virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Calderon, H. (2017). Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:da89b317-5f76-4447-bbb1-26740db3b3ef ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748889

Chicago Manual of Style (16th Edition):

Calderon, Hugo. “Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response.” 2017. Doctoral Dissertation, University of Oxford. Accessed January 21, 2021. http://ora.ox.ac.uk/objects/uuid:da89b317-5f76-4447-bbb1-26740db3b3ef ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748889.

MLA Handbook (7th Edition):

Calderon, Hugo. “Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response.” 2017. Web. 21 Jan 2021.

Vancouver:

Calderon H. Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response. [Internet] [Doctoral dissertation]. University of Oxford; 2017. [cited 2021 Jan 21]. Available from: http://ora.ox.ac.uk/objects/uuid:da89b317-5f76-4447-bbb1-26740db3b3ef ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748889.

Council of Science Editors:

Calderon H. Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response. [Doctoral Dissertation]. University of Oxford; 2017. Available from: http://ora.ox.ac.uk/objects/uuid:da89b317-5f76-4447-bbb1-26740db3b3ef ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748889


University of Ottawa

11. Jilesen, Zachary Keavin. Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme .

Degree: 2019, University of Ottawa

 Glioblastoma multiforme is the most common and lethal primary brain tumour in adults. Its aggressive and invasive phenotype makes it resistant to current standards of… (more)

Subjects/Keywords: Glioblastoma multiforme; GBM; Oncolytic virus; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jilesen, Z. K. (2019). Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/39688

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Jilesen, Zachary Keavin. “Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme .” 2019. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/39688.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Jilesen, Zachary Keavin. “Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme .” 2019. Web. 21 Jan 2021.

Vancouver:

Jilesen ZK. Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme . [Internet] [Thesis]. University of Ottawa; 2019. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/39688.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Jilesen ZK. Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme . [Thesis]. University of Ottawa; 2019. Available from: http://hdl.handle.net/10393/39688

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Virginia Tech

12. King, Jamie N. Phase I Clinical Trial of Recombinant Oncolytic Newcastle Disease Virus for Intracranial Meningioma.

Degree: MS, Biomedical and Veterinary Sciences, 2017, Virginia Tech

 Meningioma is one of the most commonly diagnosed intracranial tumors in dogs and humans. Treatment failures resulting in local recurrence and death remain common in… (more)

Subjects/Keywords: Meningioma; Newcastle Disease Virus; Canine; Oncolytic Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

King, J. N. (2017). Phase I Clinical Trial of Recombinant Oncolytic Newcastle Disease Virus for Intracranial Meningioma. (Masters Thesis). Virginia Tech. Retrieved from http://hdl.handle.net/10919/86617

Chicago Manual of Style (16th Edition):

King, Jamie N. “Phase I Clinical Trial of Recombinant Oncolytic Newcastle Disease Virus for Intracranial Meningioma.” 2017. Masters Thesis, Virginia Tech. Accessed January 21, 2021. http://hdl.handle.net/10919/86617.

MLA Handbook (7th Edition):

King, Jamie N. “Phase I Clinical Trial of Recombinant Oncolytic Newcastle Disease Virus for Intracranial Meningioma.” 2017. Web. 21 Jan 2021.

Vancouver:

King JN. Phase I Clinical Trial of Recombinant Oncolytic Newcastle Disease Virus for Intracranial Meningioma. [Internet] [Masters thesis]. Virginia Tech; 2017. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10919/86617.

Council of Science Editors:

King JN. Phase I Clinical Trial of Recombinant Oncolytic Newcastle Disease Virus for Intracranial Meningioma. [Masters Thesis]. Virginia Tech; 2017. Available from: http://hdl.handle.net/10919/86617


The Ohio State University

13. Alvarez-Breckenridge, Christopher. The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma.

Degree: PhD, Integrated Biomedical Science Graduate Program, 2011, The Ohio State University

  It is controversial as to whether the host immune response hinders or improves the efficacy of oncolytic Herpes Simplex viral (oHSV) therapy of glioblastoma… (more)

Subjects/Keywords: Oncology; oncolytic virus; natural killer cell; glioblastoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alvarez-Breckenridge, C. (2011). The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma. (Doctoral Dissertation). The Ohio State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=osu1305675390

Chicago Manual of Style (16th Edition):

Alvarez-Breckenridge, Christopher. “The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma.” 2011. Doctoral Dissertation, The Ohio State University. Accessed January 21, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=osu1305675390.

MLA Handbook (7th Edition):

Alvarez-Breckenridge, Christopher. “The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma.” 2011. Web. 21 Jan 2021.

Vancouver:

Alvarez-Breckenridge C. The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma. [Internet] [Doctoral dissertation]. The Ohio State University; 2011. [cited 2021 Jan 21]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1305675390.

Council of Science Editors:

Alvarez-Breckenridge C. The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma. [Doctoral Dissertation]. The Ohio State University; 2011. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1305675390


University of Cincinnati

14. Baird, William H. Development of a Novel Model for Exploring the Role of Regulatory T-cells in Oncolytic HSV Cancer Therapy.

Degree: MS, Medicine: Molecular and Developmental Biology, 2011, University of Cincinnati

  Cancer remains one of the scourges of modern life despite our radical advances in medical technology and treatment. The need for improved therapies is… (more)

Subjects/Keywords: Oncology; oncolytic HSV; rhabdomyosarcoma; herpes simplex virus; regulatory T-cells; T-regs; oncolytic virotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baird, W. H. (2011). Development of a Novel Model for Exploring the Role of Regulatory T-cells in Oncolytic HSV Cancer Therapy. (Masters Thesis). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1307443026

Chicago Manual of Style (16th Edition):

Baird, William H. “Development of a Novel Model for Exploring the Role of Regulatory T-cells in Oncolytic HSV Cancer Therapy.” 2011. Masters Thesis, University of Cincinnati. Accessed January 21, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1307443026.

MLA Handbook (7th Edition):

Baird, William H. “Development of a Novel Model for Exploring the Role of Regulatory T-cells in Oncolytic HSV Cancer Therapy.” 2011. Web. 21 Jan 2021.

Vancouver:

Baird WH. Development of a Novel Model for Exploring the Role of Regulatory T-cells in Oncolytic HSV Cancer Therapy. [Internet] [Masters thesis]. University of Cincinnati; 2011. [cited 2021 Jan 21]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1307443026.

Council of Science Editors:

Baird WH. Development of a Novel Model for Exploring the Role of Regulatory T-cells in Oncolytic HSV Cancer Therapy. [Masters Thesis]. University of Cincinnati; 2011. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1307443026


McMaster University

15. Newhook, Lisa. Investigating the use of T cells engineered with a T cell antigen coupler (TAC) receptor as cellular carriers of oncolytic maraba virus.

Degree: MSc, 2017, McMaster University

The field of immuno-oncology has made tremendous advances in the treatment of cancer. Adoptive cellular transfer (ACT) of tumor-specific T cells and oncolytic viruses (OVs)… (more)

Subjects/Keywords: Oncolytic Virus; T cell; immunotherapy; virus loading; cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Newhook, L. (2017). Investigating the use of T cells engineered with a T cell antigen coupler (TAC) receptor as cellular carriers of oncolytic maraba virus. (Masters Thesis). McMaster University. Retrieved from http://hdl.handle.net/11375/22812

Chicago Manual of Style (16th Edition):

Newhook, Lisa. “Investigating the use of T cells engineered with a T cell antigen coupler (TAC) receptor as cellular carriers of oncolytic maraba virus.” 2017. Masters Thesis, McMaster University. Accessed January 21, 2021. http://hdl.handle.net/11375/22812.

MLA Handbook (7th Edition):

Newhook, Lisa. “Investigating the use of T cells engineered with a T cell antigen coupler (TAC) receptor as cellular carriers of oncolytic maraba virus.” 2017. Web. 21 Jan 2021.

Vancouver:

Newhook L. Investigating the use of T cells engineered with a T cell antigen coupler (TAC) receptor as cellular carriers of oncolytic maraba virus. [Internet] [Masters thesis]. McMaster University; 2017. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/11375/22812.

Council of Science Editors:

Newhook L. Investigating the use of T cells engineered with a T cell antigen coupler (TAC) receptor as cellular carriers of oncolytic maraba virus. [Masters Thesis]. McMaster University; 2017. Available from: http://hdl.handle.net/11375/22812


University of Ottawa

16. Ghobadloo, Shahrokh. From Virus Protection to Cell Isolation and Biomarker Discovery with Aptamers .

Degree: 2017, University of Ottawa

 New affinity molecules such as nucleic acid aptamers are in demand in the science and medical fields. Current aptamer selection technologies can generate unique aptamers… (more)

Subjects/Keywords: Virus protection; Cell isolation; Biomarker discovery; Oncolytic Virus; Aptamers

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ghobadloo, S. (2017). From Virus Protection to Cell Isolation and Biomarker Discovery with Aptamers . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/36615

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ghobadloo, Shahrokh. “From Virus Protection to Cell Isolation and Biomarker Discovery with Aptamers .” 2017. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/36615.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ghobadloo, Shahrokh. “From Virus Protection to Cell Isolation and Biomarker Discovery with Aptamers .” 2017. Web. 21 Jan 2021.

Vancouver:

Ghobadloo S. From Virus Protection to Cell Isolation and Biomarker Discovery with Aptamers . [Internet] [Thesis]. University of Ottawa; 2017. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/36615.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ghobadloo S. From Virus Protection to Cell Isolation and Biomarker Discovery with Aptamers . [Thesis]. University of Ottawa; 2017. Available from: http://hdl.handle.net/10393/36615

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

17. Sahin, TT; Kasuya, H; Nomura, N; Shikano, T; Yamamura, K; Gewen, T; Kanzaki, A; Fujii, T; Sugae, T; Imai, T; Nomoto, S; Takeda, S; Sugimoto, H; Kikumori, T; Kodera, Y; Nishiyama, Y. Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer.

Degree: 博士(医学), 2018, Nagoya University / 名古屋大学

Oncolytic viruses are a promising method of cancer therapy, even for advanced malignancies. HF10, a spontaneously mutated herpes simplex type 1, is a potent oncolytic(more)

Subjects/Keywords: angiogenesis; apoptosis; breast cancer; herpes virus; HF10; oncolytic virus; microenvironment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sahin, TT; Kasuya, H; Nomura, N; Shikano, T; Yamamura, K; Gewen, T; Kanzaki, A; Fujii, T; Sugae, T; Imai, T; Nomoto, S; Takeda, S; Sugimoto, H; Kikumori, T; Kodera, Y; Nishiyama, Y. (2018). Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer. (Thesis). Nagoya University / 名古屋大学. Retrieved from http://hdl.handle.net/2237/18933

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sahin, TT; Kasuya, H; Nomura, N; Shikano, T; Yamamura, K; Gewen, T; Kanzaki, A; Fujii, T; Sugae, T; Imai, T; Nomoto, S; Takeda, S; Sugimoto, H; Kikumori, T; Kodera, Y; Nishiyama, Y. “Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer.” 2018. Thesis, Nagoya University / 名古屋大学. Accessed January 21, 2021. http://hdl.handle.net/2237/18933.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sahin, TT; Kasuya, H; Nomura, N; Shikano, T; Yamamura, K; Gewen, T; Kanzaki, A; Fujii, T; Sugae, T; Imai, T; Nomoto, S; Takeda, S; Sugimoto, H; Kikumori, T; Kodera, Y; Nishiyama, Y. “Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer.” 2018. Web. 21 Jan 2021.

Vancouver:

Sahin, TT; Kasuya, H; Nomura, N; Shikano, T; Yamamura, K; Gewen, T; Kanzaki, A; Fujii, T; Sugae, T; Imai, T; Nomoto, S; Takeda, S; Sugimoto, H; Kikumori, T; Kodera, Y; Nishiyama Y. Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer. [Internet] [Thesis]. Nagoya University / 名古屋大学; 2018. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/2237/18933.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sahin, TT; Kasuya, H; Nomura, N; Shikano, T; Yamamura, K; Gewen, T; Kanzaki, A; Fujii, T; Sugae, T; Imai, T; Nomoto, S; Takeda, S; Sugimoto, H; Kikumori, T; Kodera, Y; Nishiyama Y. Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer. [Thesis]. Nagoya University / 名古屋大学; 2018. Available from: http://hdl.handle.net/2237/18933

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Adelaide

18. Singleton, Eve Victoria. Sterility and immunogenicity of gamma-irradiated respiratory viruses.

Degree: 2020, University of Adelaide

 Gamma (γ)-radiation is a method commonly applied to sterilise pathogens in the biomedical, food and pharmaceutical industries. γ-radiation inactivates pathogens by causing irreparable damage to… (more)

Subjects/Keywords: Gamma radiation; Influenza A virus; Newcastle disease virus; vaccine; oncolytic virotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Singleton, E. V. (2020). Sterility and immunogenicity of gamma-irradiated respiratory viruses. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/128819

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Singleton, Eve Victoria. “Sterility and immunogenicity of gamma-irradiated respiratory viruses.” 2020. Thesis, University of Adelaide. Accessed January 21, 2021. http://hdl.handle.net/2440/128819.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Singleton, Eve Victoria. “Sterility and immunogenicity of gamma-irradiated respiratory viruses.” 2020. Web. 21 Jan 2021.

Vancouver:

Singleton EV. Sterility and immunogenicity of gamma-irradiated respiratory viruses. [Internet] [Thesis]. University of Adelaide; 2020. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/2440/128819.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Singleton EV. Sterility and immunogenicity of gamma-irradiated respiratory viruses. [Thesis]. University of Adelaide; 2020. Available from: http://hdl.handle.net/2440/128819

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


The Ohio State University

19. Bolyard, Chelsea M. Oncolytic Virus Therapy in Combination with Chemotherapy for Ovarian Cancer.

Degree: PhD, Integrated Biomedical Science Graduate Program, 2013, The Ohio State University

 Purpose. Novel therapeutic regimens are needed to improve dismal outcomes associated with late-stage ovarian cancer. Oncolytic viruses have shown efficacy against ovarian cancer. We studied… (more)

Subjects/Keywords: Biomedical Research; oncolytic virus, herpes simplex virus, ovarian cancer, doxorubicin, synergy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bolyard, C. M. (2013). Oncolytic Virus Therapy in Combination with Chemotherapy for Ovarian Cancer. (Doctoral Dissertation). The Ohio State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=osu1386007453

Chicago Manual of Style (16th Edition):

Bolyard, Chelsea M. “Oncolytic Virus Therapy in Combination with Chemotherapy for Ovarian Cancer.” 2013. Doctoral Dissertation, The Ohio State University. Accessed January 21, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=osu1386007453.

MLA Handbook (7th Edition):

Bolyard, Chelsea M. “Oncolytic Virus Therapy in Combination with Chemotherapy for Ovarian Cancer.” 2013. Web. 21 Jan 2021.

Vancouver:

Bolyard CM. Oncolytic Virus Therapy in Combination with Chemotherapy for Ovarian Cancer. [Internet] [Doctoral dissertation]. The Ohio State University; 2013. [cited 2021 Jan 21]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1386007453.

Council of Science Editors:

Bolyard CM. Oncolytic Virus Therapy in Combination with Chemotherapy for Ovarian Cancer. [Doctoral Dissertation]. The Ohio State University; 2013. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1386007453


University of Edinburgh

20. Jadhav, Archana Chandrabhan. Molecular mechanisms of oncolytic properties of Newcastle disease virus (NDV) in human cancer cells.

Degree: PhD, 2020, University of Edinburgh

 Newcastle disease virus (NDV) is a single-stranded, non-segmented, negative-sense enveloped RNA virus, which belongs to the Orthoavulavirus genus of Paramyxoviridae family. It is a well-known,… (more)

Subjects/Keywords: Newcastle disease virus; NDV; Oncolytic virus; Caco-2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jadhav, A. C. (2020). Molecular mechanisms of oncolytic properties of Newcastle disease virus (NDV) in human cancer cells. (Doctoral Dissertation). University of Edinburgh. Retrieved from https://doi.org/10.7488/era/523 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.814903

Chicago Manual of Style (16th Edition):

Jadhav, Archana Chandrabhan. “Molecular mechanisms of oncolytic properties of Newcastle disease virus (NDV) in human cancer cells.” 2020. Doctoral Dissertation, University of Edinburgh. Accessed January 21, 2021. https://doi.org/10.7488/era/523 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.814903.

MLA Handbook (7th Edition):

Jadhav, Archana Chandrabhan. “Molecular mechanisms of oncolytic properties of Newcastle disease virus (NDV) in human cancer cells.” 2020. Web. 21 Jan 2021.

Vancouver:

Jadhav AC. Molecular mechanisms of oncolytic properties of Newcastle disease virus (NDV) in human cancer cells. [Internet] [Doctoral dissertation]. University of Edinburgh; 2020. [cited 2021 Jan 21]. Available from: https://doi.org/10.7488/era/523 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.814903.

Council of Science Editors:

Jadhav AC. Molecular mechanisms of oncolytic properties of Newcastle disease virus (NDV) in human cancer cells. [Doctoral Dissertation]. University of Edinburgh; 2020. Available from: https://doi.org/10.7488/era/523 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.814903


University of Ottawa

21. Davis, Colin. Comparative Study of Colon Cancer Subclones Uncovers Potential Roles for AKAP7 and TP53RK in the Antiviral Response.

Degree: 2016, University of Ottawa

 Tumour heterogeneity is a key hurdle for the effective treatment of cancer using oncolytic viruses (OVs). A better understanding of the pathways involved in delineating… (more)

Subjects/Keywords: Oncolytic Virus; Antiviral; CT26; Clone; Heterogeneity; JAK-STAT; Viral Sensitivity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Davis, C. (2016). Comparative Study of Colon Cancer Subclones Uncovers Potential Roles for AKAP7 and TP53RK in the Antiviral Response. (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/34183

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Davis, Colin. “Comparative Study of Colon Cancer Subclones Uncovers Potential Roles for AKAP7 and TP53RK in the Antiviral Response. ” 2016. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/34183.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Davis, Colin. “Comparative Study of Colon Cancer Subclones Uncovers Potential Roles for AKAP7 and TP53RK in the Antiviral Response. ” 2016. Web. 21 Jan 2021.

Vancouver:

Davis C. Comparative Study of Colon Cancer Subclones Uncovers Potential Roles for AKAP7 and TP53RK in the Antiviral Response. [Internet] [Thesis]. University of Ottawa; 2016. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/34183.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Davis C. Comparative Study of Colon Cancer Subclones Uncovers Potential Roles for AKAP7 and TP53RK in the Antiviral Response. [Thesis]. University of Ottawa; 2016. Available from: http://hdl.handle.net/10393/34183

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Dalhousie University

22. Garant, Katy. Oncolytic Reovirus Induces Intracellular Redistribution of Ras to Promote Apoptosis and Progeny Virus Release.

Degree: PhD, Department of Microbiology & Immunology, 2014, Dalhousie University

 Ras is a dynamic protein capable of interacting with plasma membrane microdomains and intracellular membranes. Its activity, as controlled by post-translational modifications, is essential in… (more)

Subjects/Keywords: Reovirus; Ras; Cancer Biology; Oncolytic Virus; Palmitoylation; Apoptosis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Garant, K. (2014). Oncolytic Reovirus Induces Intracellular Redistribution of Ras to Promote Apoptosis and Progeny Virus Release. (Doctoral Dissertation). Dalhousie University. Retrieved from http://hdl.handle.net/10222/54002

Chicago Manual of Style (16th Edition):

Garant, Katy. “Oncolytic Reovirus Induces Intracellular Redistribution of Ras to Promote Apoptosis and Progeny Virus Release.” 2014. Doctoral Dissertation, Dalhousie University. Accessed January 21, 2021. http://hdl.handle.net/10222/54002.

MLA Handbook (7th Edition):

Garant, Katy. “Oncolytic Reovirus Induces Intracellular Redistribution of Ras to Promote Apoptosis and Progeny Virus Release.” 2014. Web. 21 Jan 2021.

Vancouver:

Garant K. Oncolytic Reovirus Induces Intracellular Redistribution of Ras to Promote Apoptosis and Progeny Virus Release. [Internet] [Doctoral dissertation]. Dalhousie University; 2014. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10222/54002.

Council of Science Editors:

Garant K. Oncolytic Reovirus Induces Intracellular Redistribution of Ras to Promote Apoptosis and Progeny Virus Release. [Doctoral Dissertation]. Dalhousie University; 2014. Available from: http://hdl.handle.net/10222/54002


McMaster University

23. Stephenson, Kyle B. IMPROVING ONCOLYTIC VESICULAR STOMATITIS VIRUS THROUGH MODULATION OF THE ANTI-TUMOUR IMMUNE RESPONSE.

Degree: PhD, 2013, McMaster University

Despite improvements in detection and treatment, cancer is the leading cause of death worldwide. Current treatment modalities have not been able to improve the… (more)

Subjects/Keywords: Oncolytic Virus; VSV; cancer biotherapeutics; p14 FAST; IL-15; Virology; Virology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Stephenson, K. B. (2013). IMPROVING ONCOLYTIC VESICULAR STOMATITIS VIRUS THROUGH MODULATION OF THE ANTI-TUMOUR IMMUNE RESPONSE. (Doctoral Dissertation). McMaster University. Retrieved from http://hdl.handle.net/11375/12900

Chicago Manual of Style (16th Edition):

Stephenson, Kyle B. “IMPROVING ONCOLYTIC VESICULAR STOMATITIS VIRUS THROUGH MODULATION OF THE ANTI-TUMOUR IMMUNE RESPONSE.” 2013. Doctoral Dissertation, McMaster University. Accessed January 21, 2021. http://hdl.handle.net/11375/12900.

MLA Handbook (7th Edition):

Stephenson, Kyle B. “IMPROVING ONCOLYTIC VESICULAR STOMATITIS VIRUS THROUGH MODULATION OF THE ANTI-TUMOUR IMMUNE RESPONSE.” 2013. Web. 21 Jan 2021.

Vancouver:

Stephenson KB. IMPROVING ONCOLYTIC VESICULAR STOMATITIS VIRUS THROUGH MODULATION OF THE ANTI-TUMOUR IMMUNE RESPONSE. [Internet] [Doctoral dissertation]. McMaster University; 2013. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/11375/12900.

Council of Science Editors:

Stephenson KB. IMPROVING ONCOLYTIC VESICULAR STOMATITIS VIRUS THROUGH MODULATION OF THE ANTI-TUMOUR IMMUNE RESPONSE. [Doctoral Dissertation]. McMaster University; 2013. Available from: http://hdl.handle.net/11375/12900


University of Toronto

24. Ho, Tiffany Yun-Yee. Designing the Next-generation Oncolytic Vaccinia Virus.

Degree: 2017, University of Toronto

Many oncolytic viruses (OVs), such as double-deleted vaccina virus (vvDD), are engineered with enhanced tumor-selectivity based on increased cell proliferation in cancer cells. We proposed… (more)

Subjects/Keywords: Cancer therapy; Interferon; Oncolytic virotherapy; Peritoneal Carcinomatosis; Vaccinia Virus; vvDD; 0992

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ho, T. Y. (2017). Designing the Next-generation Oncolytic Vaccinia Virus. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/77794

Chicago Manual of Style (16th Edition):

Ho, Tiffany Yun-Yee. “Designing the Next-generation Oncolytic Vaccinia Virus.” 2017. Masters Thesis, University of Toronto. Accessed January 21, 2021. http://hdl.handle.net/1807/77794.

MLA Handbook (7th Edition):

Ho, Tiffany Yun-Yee. “Designing the Next-generation Oncolytic Vaccinia Virus.” 2017. Web. 21 Jan 2021.

Vancouver:

Ho TY. Designing the Next-generation Oncolytic Vaccinia Virus. [Internet] [Masters thesis]. University of Toronto; 2017. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/1807/77794.

Council of Science Editors:

Ho TY. Designing the Next-generation Oncolytic Vaccinia Virus. [Masters Thesis]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/77794


Western Michigan University

25. Zhang, Tiantian. Oncolytic Tanapoxvirus for Melanoma Therapy.

Degree: PhD, Biological Sciences, 2017, Western Michigan University

Oncolytic viruses (OVs), which preferentially infect cancer cells and induce host anti- tumor immune responses, have emerged as an effective melanoma therapy. Tanapoxvirus (TPV),… (more)

Subjects/Keywords: Melanoma; oncolytic virus; tanapoxvirus; immunotherapy; viral immune-modulators; cancer treatment; Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhang, T. (2017). Oncolytic Tanapoxvirus for Melanoma Therapy. (Doctoral Dissertation). Western Michigan University. Retrieved from https://scholarworks.wmich.edu/dissertations/3121

Chicago Manual of Style (16th Edition):

Zhang, Tiantian. “Oncolytic Tanapoxvirus for Melanoma Therapy.” 2017. Doctoral Dissertation, Western Michigan University. Accessed January 21, 2021. https://scholarworks.wmich.edu/dissertations/3121.

MLA Handbook (7th Edition):

Zhang, Tiantian. “Oncolytic Tanapoxvirus for Melanoma Therapy.” 2017. Web. 21 Jan 2021.

Vancouver:

Zhang T. Oncolytic Tanapoxvirus for Melanoma Therapy. [Internet] [Doctoral dissertation]. Western Michigan University; 2017. [cited 2021 Jan 21]. Available from: https://scholarworks.wmich.edu/dissertations/3121.

Council of Science Editors:

Zhang T. Oncolytic Tanapoxvirus for Melanoma Therapy. [Doctoral Dissertation]. Western Michigan University; 2017. Available from: https://scholarworks.wmich.edu/dissertations/3121


University of Ottawa

26. Marguerie, Monique. Combining the Immunogenic Cancer Mutanome with Oncolytic Virus Therapy .

Degree: 2014, University of Ottawa

Oncolytic viruses (OVs) are effective anti-cancer agents, however their abilities to induce anti-tumor immunity are not yet optimal. Mutanome epitopes are a novel source of… (more)

Subjects/Keywords: oncolytic virus; mutanome; multi-epitope; prime-boost; maraba; adenovirus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Marguerie, M. (2014). Combining the Immunogenic Cancer Mutanome with Oncolytic Virus Therapy . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/31409

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Marguerie, Monique. “Combining the Immunogenic Cancer Mutanome with Oncolytic Virus Therapy .” 2014. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/31409.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Marguerie, Monique. “Combining the Immunogenic Cancer Mutanome with Oncolytic Virus Therapy .” 2014. Web. 21 Jan 2021.

Vancouver:

Marguerie M. Combining the Immunogenic Cancer Mutanome with Oncolytic Virus Therapy . [Internet] [Thesis]. University of Ottawa; 2014. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/31409.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Marguerie M. Combining the Immunogenic Cancer Mutanome with Oncolytic Virus Therapy . [Thesis]. University of Ottawa; 2014. Available from: http://hdl.handle.net/10393/31409

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Ottawa

27. Aitken, Amelia. Blocking the RNA Interference Pathway Improves Oncolytic Virus Therapy .

Degree: 2017, University of Ottawa

Oncolytic viruses are novel candidates for cancer therapy and their efficacy relies on their capacity to overcome the host’s anti-viral barriers. In mammalian cells, the… (more)

Subjects/Keywords: Cancer; Oncolytic virus; RNA; microRNA; RNAi; RNA silencing; Cancer therapy; Dicer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Aitken, A. (2017). Blocking the RNA Interference Pathway Improves Oncolytic Virus Therapy . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/36821

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Aitken, Amelia. “Blocking the RNA Interference Pathway Improves Oncolytic Virus Therapy .” 2017. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/36821.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Aitken, Amelia. “Blocking the RNA Interference Pathway Improves Oncolytic Virus Therapy .” 2017. Web. 21 Jan 2021.

Vancouver:

Aitken A. Blocking the RNA Interference Pathway Improves Oncolytic Virus Therapy . [Internet] [Thesis]. University of Ottawa; 2017. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/36821.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Aitken A. Blocking the RNA Interference Pathway Improves Oncolytic Virus Therapy . [Thesis]. University of Ottawa; 2017. Available from: http://hdl.handle.net/10393/36821

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Queen Mary, University of London

28. Whilding, Lynsey May. Activity of oncolytic vaccinia virus vectors in ovarian cancer.

Degree: PhD, 2012, Queen Mary, University of London

Oncolytic vaccinia virus has great potential in the treatment of cancer and two engineered strains have entered clinical trials. As the advent for oncolytic vaccinia… (more)

Subjects/Keywords: 616.99465; Medicine; Molecular Oncology; Ovarian cancer; Oncolytic vaccinia virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Whilding, L. M. (2012). Activity of oncolytic vaccinia virus vectors in ovarian cancer. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/8553 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.554923

Chicago Manual of Style (16th Edition):

Whilding, Lynsey May. “Activity of oncolytic vaccinia virus vectors in ovarian cancer.” 2012. Doctoral Dissertation, Queen Mary, University of London. Accessed January 21, 2021. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8553 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.554923.

MLA Handbook (7th Edition):

Whilding, Lynsey May. “Activity of oncolytic vaccinia virus vectors in ovarian cancer.” 2012. Web. 21 Jan 2021.

Vancouver:

Whilding LM. Activity of oncolytic vaccinia virus vectors in ovarian cancer. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2012. [cited 2021 Jan 21]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8553 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.554923.

Council of Science Editors:

Whilding LM. Activity of oncolytic vaccinia virus vectors in ovarian cancer. [Doctoral Dissertation]. Queen Mary, University of London; 2012. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8553 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.554923


University of Ottawa

29. Wedge, Marie-Ève. Tailoring Oncolytic Viruses for the Treatment of Pancreatic Cancer .

Degree: 2020, University of Ottawa

 Pancreatic cancer (PC) is a highly aggressive disease with unmet therapeutic needs. Recent advances in the use of oncolytic viruses (OVs) as cancer therapeutic agents… (more)

Subjects/Keywords: Oncolytic virus; Pancreatic cancer; Extracellular vesicles; microRNA; Synthetic lethality; Bystander effect

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wedge, M. (2020). Tailoring Oncolytic Viruses for the Treatment of Pancreatic Cancer . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/40384

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Wedge, Marie-Ève. “Tailoring Oncolytic Viruses for the Treatment of Pancreatic Cancer .” 2020. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/40384.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Wedge, Marie-Ève. “Tailoring Oncolytic Viruses for the Treatment of Pancreatic Cancer .” 2020. Web. 21 Jan 2021.

Vancouver:

Wedge M. Tailoring Oncolytic Viruses for the Treatment of Pancreatic Cancer . [Internet] [Thesis]. University of Ottawa; 2020. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/40384.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wedge M. Tailoring Oncolytic Viruses for the Treatment of Pancreatic Cancer . [Thesis]. University of Ottawa; 2020. Available from: http://hdl.handle.net/10393/40384

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Ottawa

30. Skillings, Robyn. Neurosafety and Oncotropism of the Oncolytic Farmington Virus in the Treatment of Glioblastoma Multiforme .

Degree: 2020, University of Ottawa

 Glioblastoma multiforme is the most common and malignant form of brain cancer in humans. The current prognosis for glioblastoma patients undergoing standard treatment is extremely… (more)

Subjects/Keywords: Oncolytic virus; Glioblastoma; Virology; Viral glycoprotein; Neurosafety; Interferon; Oncotropism; Rhabdovirus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Skillings, R. (2020). Neurosafety and Oncotropism of the Oncolytic Farmington Virus in the Treatment of Glioblastoma Multiforme . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/40292

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Skillings, Robyn. “Neurosafety and Oncotropism of the Oncolytic Farmington Virus in the Treatment of Glioblastoma Multiforme .” 2020. Thesis, University of Ottawa. Accessed January 21, 2021. http://hdl.handle.net/10393/40292.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Skillings, Robyn. “Neurosafety and Oncotropism of the Oncolytic Farmington Virus in the Treatment of Glioblastoma Multiforme .” 2020. Web. 21 Jan 2021.

Vancouver:

Skillings R. Neurosafety and Oncotropism of the Oncolytic Farmington Virus in the Treatment of Glioblastoma Multiforme . [Internet] [Thesis]. University of Ottawa; 2020. [cited 2021 Jan 21]. Available from: http://hdl.handle.net/10393/40292.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Skillings R. Neurosafety and Oncotropism of the Oncolytic Farmington Virus in the Treatment of Glioblastoma Multiforme . [Thesis]. University of Ottawa; 2020. Available from: http://hdl.handle.net/10393/40292

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4]

.